The steroidogenic theory of sarcopenia has been linked to changes in insulin-like growth factor-1 (IGF-1), a principal anabolic myokine (141), and development of depression has been linked to both low and high, but not median, circulating IGF-1 levels in elderly populations (142). The gene discussed is IGF1; the disease is depressive symptom measurement.